# Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

> **NCT04107077** · PHASE2 · RECRUITING · sponsor: **University of Chicago** · enrollment: 21 (estimated)

## Conditions studied

- Gastric Cancer
- Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Mitomycin

## Key facts

- **NCT ID:** NCT04107077
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-09
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04107077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04107077, "Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04107077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*